http://www.fpnotebook.com/
Idiopathic Interstitial Pneumonia
Aka: Idiopathic Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Usual Interstitial Pneumonia, Desquamative Interstitial Pneumonia, Respiratory Bronchiolitis, RB-ILD, Acute Interstitial Pneumonia, Hamman-Rich Disease, Nonspecific Interstitial Pneumonia
- Epidemiology
- Prevalence
- Men: 29 per 100,000
- Women: 26 per 100,000
- Ages: 40-70 years
- Types of Idiopathic Interstitial Pneumonia
- Usual Interstitial Pneumonia (UIP)
- Previously known as Idiopathic Pulmonary Fibrosis
- Associated conditions
- Collagen vascular disease
- Drug Reaction (Nitrofurantoin)
- Pneumoconioses (Asbestosis)
- Idiopathic Pulmonary Fibrosis (IPF)
- Imaging appearance: Honey combing
- Poor response to Corticosteroids
- Recovery not possible
- Mortality 68% with mean survival 5-6 years
- Desquamative Interstitial Pneumonia (DIP)
- Imaging appearance: Ground Glass Appearance
- Good response to Corticosteroids
- Mortality 27% with mean survival 12 years
- Respiratory Bronchiolitis (RB-ILD)
- Imaging appearance: Ground Glass Appearance
- Good response to Corticosteroids
- Mortality 0%
- Acute Interstitial Pneumonia (AIP)
- Also known as Hamman-Rich Disease
- Acute, severe Interstitial Lung Disease
- Poor response to Corticosteroids
- Mortality 62% with mean survival 1-2 months
- Nonspecific Interstitial Pneumonia (NSIP)
- Subacute onset
- Good response to Corticosteroids
- Mortality 11% with mean survival 17 months
- Symptoms
- Non-productive cough for 1 to 3 years
- Increasing breathlessness
- Signs
- Bilateral basilar crackles
- FingernailClubbing
- Associated Conditions
- Associated autoimmune disease in 30%
- Radiology
- Chest XRay (Normal in 16% of IPF patients)
- Diffuse reticular pattern
- Predominately lower zones
- CT Chest
- Linear opacities, honeycombing
- Ground glass attenuation
- Diagnosis
- Pulmonary Function Testing
- Restrictive disease
- Low Lung Volumes
- Impaired gas exchange (diminished DLCO)
- Transbronchial lung biopsy or Bronchoalveolar lavage
- Will not confirm IPF
- Rules out other causes of Interstitial Lung Disease
- Sarcoidosis
- Cryptococcus
- Lung Cancer
- Differential Diagnosis
- See also Interstitial Lung Disease
- Other causes of fibrosing alveolitis
- Occupational exposure etiologies
- Management
- Corticosteroid Therapy
- Efficacy
- Corticosteroid Responders: 10-15%
- Indicators of responders
- Young women
- Ground glass appearance on CT Chest
- Active inflammation on lung biopsy
- Adverse Effects
- Serious complications in 26%
- Cytotoxic Drugs
- Available preparations
- Azathioprine
- Cyclophosphamide
- Indications
- Second line drugs
- Used in combination with Corticosteroids
- Prognosis
- Poor (recently improved on combination therapy)
- Resources
- Pulmonary Fibrosis Association
- http://www.pulmonaryfibrosisassn.com/
- Pulmonary Fibrosis Foundation
- http://www.pulmonaryfibrosis.org
- References
- Chan-Yeung (1997) Lancet 350:651-6